TABLE OF CONTENTS

TABLE OF CONTENTS

Abstract

Journal of the National Cancer Institute JNCI February 2, 2011, Volume 103, Number 3 Pages 163–281 jnci.oxfordjournals.org 163 194 196 170 171 172 173 175 178 232 241 In This Issue Editorials Stage I Seminoma: Adjuvant Treatment is Effective but is it Necessary? P. Chung, P. Warde Assessing the Quality and Value of Quality-of-Life Measurement in Breast Cancer Clinical Trials, P.A. Ganz News Getting Around PLX4032: Studies Turn Up Unusual Mechanisms of Resistance to Melanoma Drug, R.S. Tuma Stat Bite: Melanoma Incidence: 1992–2007 Materials Scientists Join Oncologists To Explore Nano- and Microtherapeutics, M. Martin Nanoimaging Devices Illuminate Tumor Margins During Surgery, M. Patlak Abiraterone and MVD3100 Take Androgen Deprivation to a New Level, C. Schmidt Reviews Quality-of-Life Measurement in Randomized Clinical Trials in Breast Cancer: An Updated Systematic Review (2001–2009), J. Lemieux, P.J. Goodwin, L.J. Bordeleau, S. Lauzier, V. Théberge Osteonecrosis of the Jaw and the Role of Macrophages, M. Pazianas Articles Randomized Trials in 2466 Patients With Stage I Seminoma: Patterns of Relapse and Follow-up, G.M. Mead, S.D. Fossa, R.T.D. Oliver, J.K. Joffe, R.A. Huddart, J.T. Roberts, P. Pollock, R. Gabe, S.P. Stenning Associations of Breast Cancer Risk Factors With Tumor Subtypes: A Pooled Analysis From the